Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,37249,405,3.29 [1.83-5.90],6.434114072282676e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41668,448,1.38 [1.25-1.52],4.019026722797775e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,37239,408,2.51 [1.76-3.58],3.193095376345696e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,41880,443,1.70 [1.48-1.95],3.2474960362303085e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,36116,394,0.62 [0.48-0.79],0.0001126859531522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,42866,459,1.96 [1.55-2.48],1.7153745740329875e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,36116,394,0.85 [0.75-0.96],0.0099504873326046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",41880,443,1.39 [1.18-1.63],6.65229788260347e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,42294,453,2.61 [1.95-3.50],1.5177610030738183e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,42691,456,1.31 [1.16-1.49],2.09612028658542e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,35986,394,1.40 [1.19-1.65],5.487311774929657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,43147,461,1.41 [1.13-1.75],0.0021857234051259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,42423,454,1.89 [1.57-2.26],8.21555771009886e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36116,394,1.91 [1.61-2.27],1.7572954018179705e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41880,443,1.77 [1.34-2.33],5.695483453831583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42367,453,0.52 [0.41-0.66],6.111212147039264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,43147,461,0.73 [0.58-0.91],0.0053670200748018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,43004,460,1.69 [1.28-2.22],0.0001750554156715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37041,407,2.45 [1.86-3.23],1.9136137713211011e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36116,394,1.64 [1.25-2.14],0.0003105428580191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,43204,461,0.45 [0.31-0.63],5.002061051766659e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42503,452,1.60 [1.30-1.97],9.45985146299771e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,37205,407,3.38 [2.68-4.27],8.776820052987807e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,36382,391,2.18 [1.76-2.71],9.53464501717999e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,37041,407,1.33 [1.12-1.58],0.0012409233689765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,42503,452,1.38 [1.26-1.52],1.3759602402506339e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,37249,405,1.49 [1.29-1.72],5.1277985007795e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,43059,464,4.45 [3.25-6.08],9.346265011560964e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,36382,391,0.84 [0.74-0.95],0.007461762088051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,41370,434,1.20 [1.10-1.31],3.241936544298002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,42864,461,1.81 [1.46-2.23],5.4358511044429634e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,42691,456,1.24 [1.12-1.38],4.171534528550116e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,36223,386,1.54 [1.16-2.06],0.0032199612987085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42433,452,1.17 [1.08-1.26],0.0001184747642717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,36175,396,1.28 [1.11-1.48],0.0006577659074264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,43204,461,2.27 [1.52-3.37],5.341875424940488e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,42688,457,1.26 [1.08-1.45],0.0023889902130645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42550,453,1.37 [1.24-1.51],4.3406732111982526e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37147,408,1.51 [1.25-1.82],1.3570345555020904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",42503,452,1.28 [1.20-1.36],4.93355774011628e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,42997,461,1.90 [1.26-2.87],0.0021128727946308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,41019,440,0.76 [0.64-0.91],0.0032059780732588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,39767,426,0.72 [0.60-0.86],0.0004051621200672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,42565,455,1.53 [1.20-1.94],0.0005231114007627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,43059,464,2.70 [2.23-3.27],1.990982469002913e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,42075,443,2.35 [1.76-3.14],7.659200955570108e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,42729,460,1.40 [1.14-1.72],0.0014455112638808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,42706,456,1.59 [1.25-2.02],0.0001482669244004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,42795,460,1.86 [1.55-2.23],2.6969950786579856e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,43059,464,1.51 [1.22-1.87],0.0001218018020817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,42777,457,1.85 [1.38-2.47],3.5078273614665625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,41707,446,1.40 [1.28-1.54],8.17361969720657e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,35669,382,1.24 [1.09-1.41],0.0008337812044371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,42847,457,2.38 [1.80-3.15],1.4832594762864362e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,42691,456,0.67 [0.57-0.80],4.879264130976361e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,37239,408,1.38 [1.14-1.68],0.0011549895744333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,42503,452,2.35 [2.02-2.72],2.3617632154847866e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,36852,406,1.47 [1.22-1.77],4.18695960081172e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,42367,453,2.64 [2.06-3.40],2.8760328559322614e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,37239,408,2.29 [1.63-3.24],2.264667582442196e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,37203,406,1.68 [1.26-2.25],0.0003994075562708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,37041,407,1.60 [1.28-2.00],3.769414445637999e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,37249,405,1.71 [1.41-2.07],4.744855464422904e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36223,386,1.90 [1.44-2.50],4.993033866165211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",42864,461,2.30 [1.72-3.07],1.896549233764943e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41668,448,1.35 [1.19-1.53],2.112229447506632e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,41668,448,1.54 [1.17-2.02],0.0020132730732005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,37122,409,1.18 [1.04-1.34],0.009457465690286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,42688,457,2.07 [1.50-2.85],9.392374891719774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,42367,453,0.34 [0.26-0.43],9.85506953320492e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37203,406,1.59 [1.21-2.09],0.0008285661654678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,36554,398,0.61 [0.44-0.83],0.0020428662850199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42620,454,1.38 [1.11-1.70],0.0035210026843395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,36382,391,1.71 [1.20-2.45],0.0033161903353039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,36382,391,2.71 [1.89-3.90],6.595988000902482e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36116,394,1.40 [1.13-1.73],0.0017266405723978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,42584,455,1.56 [1.36-1.79],9.247675460327723e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,43075,460,4.74 [3.27-6.86],1.643184735062719e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,43074,461,1.70 [1.51-1.92],6.634885324859748e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,42864,461,2.08 [1.55-2.79],1.1320942772513615e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,42620,454,1.64 [1.34-2.01],1.6621913569846916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,42933,458,2.11 [1.48-2.99],3.272915793621661e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42847,457,1.76 [1.48-2.11],3.81162525058917e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,37249,405,1.94 [1.24-3.02],0.0036973902334086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,42779,457,1.83 [1.22-2.74],0.0035051411040866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,41633,446,1.30 [1.08-1.57],0.0058629630188983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,35368,380,1.31 [1.09-1.58],0.0046678305598189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,37249,405,2.25 [1.27-4.01],0.0057885151702502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,36351,397,4.35 [3.33-5.68],3.332080228572638e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,37239,408,1.29 [1.08-1.54],0.0047791285611899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,42503,452,1.76 [1.40-2.22],1.3828182228038416e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,43059,464,0.46 [0.37-0.58],9.359662453324372e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,43204,461,2.50 [1.79-3.49],6.822199164731725e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",41880,443,1.19 [1.09-1.30],7.61359313703922e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,42557,457,0.73 [0.64-0.83],3.2537247477249386e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,43059,464,1.69 [1.45-1.98],2.985172542661815e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,36175,396,1.36 [1.12-1.66],0.0020460558951831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,42293,453,1.38 [1.23-1.55],2.1060855520333583e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,42361,454,1.34 [1.17-1.53],2.084913410207904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,37037,409,1.34 [1.07-1.66],0.009640632280569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,37122,409,1.12 [1.03-1.22],0.0096583092354957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,42627,456,1.19 [1.06-1.33],0.0040517195931816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,43059,464,0.51 [0.40-0.66],3.618663891988109e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,36223,386,1.37 [1.15-1.64],0.0003736233488406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,42691,456,2.10 [1.70-2.60],7.634614193537944e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,43147,461,1.55 [1.24-1.93],0.0001018193297139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,43204,461,1.56 [1.31-1.85],4.778563653454193e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,43204,461,1.58 [1.33-1.86],1.009499940425985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,42585,458,1.17 [1.07-1.28],0.0005168081092054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,43147,461,1.39 [1.29-1.50],6.502602491489922e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,42864,461,2.03 [1.76-2.34],8.198024583447748e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,42248,452,1.63 [1.41-1.88],4.103354435543587e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,43147,461,1.32 [1.12-1.57],0.0010511863153324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,42490,451,1.42 [1.25-1.62],8.852877302142217e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,42620,454,1.35 [1.20-1.54],2.091270861736672e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,43133,458,1.84 [1.48-2.29],3.8760237505832966e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,43059,464,1.39 [1.13-1.70],0.0015749737896756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,37041,407,1.44 [1.15-1.81],0.0017797761149636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,41809,448,2.25 [1.87-2.71],1.1895300225666484e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,42847,457,1.84 [1.54-2.21],3.248161703275856e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,41777,444,1.54 [1.24-1.92],9.719450558798652e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,42814,456,1.95 [1.63-2.33],3.6324172807947524e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,42367,453,1.90 [1.53-2.36],4.4027595769012205e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,42656,457,2.13 [1.68-2.70],4.1270150745800707e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,41668,448,1.41 [1.15-1.73],0.0011534822414216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,36382,391,1.83 [1.33-2.51],0.0001852942744767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,43074,461,2.01 [1.61-2.52],9.685194715337711e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,42925,464,2.09 [1.74-2.50],2.7314920318086788e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,43059,464,1.50 [1.30-1.75],7.569101182614265e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,42688,457,1.39 [1.11-1.74],0.0042668309377966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,42503,452,2.65 [2.10-3.34],2.470987130896848e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,42929,461,0.58 [0.41-0.83],0.0025664402400981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42503,452,0.67 [0.51-0.87],0.003260716574816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,42560,452,1.73 [1.38-2.15],1.170861362238132e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,42654,459,1.38 [1.17-1.61],8.198594898581903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,42424,453,1.46 [1.10-1.94],0.0088356097081949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,42795,460,2.27 [1.74-2.96],1.2271651996604878e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,41181,432,1.59 [1.17-2.15],0.0028329117428245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,41146,445,1.81 [1.31-2.50],0.0003524955810169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,37041,402,1.56 [1.27-1.91],1.6193919930193056e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,36046,393,1.46 [1.18-1.81],0.0004856717527292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,42620,454,1.63 [1.34-1.97],7.935813610215251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,43074,461,2.06 [1.65-2.57],1.213631670537528e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,43147,461,1.43 [1.20-1.69],5.052785507675428e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,37203,406,2.63 [2.06-3.36],7.0466584959923376e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,42620,454,2.45 [1.98-3.02],1.6183089695877863e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,37041,407,1.56 [1.13-2.16],0.0064611041193762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,41082,440,1.57 [1.20-2.06],0.0010777243252521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,42688,457,2.06 [1.47-2.88],2.7642090711286885e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,42367,453,1.77 [1.54-2.02],1.8193698344521879e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,43000,461,0.81 [0.70-0.94],0.0062596748941475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,42691,456,1.92 [1.53-2.41],2.1333847429678733e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,42503,452,1.33 [1.18-1.51],5.811418603397532e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,42691,456,0.57 [0.46-0.70],5.1263459249690494e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42726,459,1.62 [1.18-2.23],0.0029643303525461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42747,453,5.09 [3.57-7.26],2.7437897383526055e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37041,407,0.55 [0.49-0.61],5.420257284578519e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37041,407,1.58 [1.24-2.00],0.0001844019835466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42620,454,1.14 [1.03-1.25],0.0086141781168362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41140,439,1.57 [1.41-1.76],1.368204272662642e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37205,407,1.88 [1.59-2.22],6.75930089788519e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41880,443,1.48 [1.27-1.73],6.184294553188444e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,43129,460,0.82 [0.71-0.94],0.0050418844012763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,42781,456,1.17 [1.06-1.28],0.0017828362401412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,42503,452,1.22 [1.06-1.41],0.0067394048470602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,36577,395,1.85 [1.37-2.50],6.204116477424596e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,35093,382,2.43 [1.58-3.74],5.2033098401505736e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,42688,457,1.33 [1.19-1.50],1.2986185631370576e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,36175,396,1.44 [1.17-1.78],0.0006995415011383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,42691,456,1.68 [1.39-2.03],6.227972306095958e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37122,409,1.93 [1.59-2.33],1.445986787108688e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,37037,409,2.14 [1.66-2.75],3.160436624222563e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,37205,407,1.49 [1.37-1.63],2.2176793867905706e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,41728,444,1.58 [1.45-1.72],1.384559974742716e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,42788,454,1.46 [1.12-1.90],0.0055552523113756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,42795,460,2.43 [1.90-3.12],2.671567909445032e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,37205,407,1.61 [1.34-1.94],3.586420021511065e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,36175,396,1.34 [1.10-1.63],0.0035900495528785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,42935,459,2.35 [1.83-3.02],2.1765729029793565e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,37205,407,1.78 [1.52-2.09],1.0012887992561905e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42511,456,1.27 [1.11-1.45],0.0004657048545496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,42367,453,1.50 [1.19-1.90],0.0007531251438447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,42614,457,1.28 [1.07-1.53],0.0064399324868918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,42688,457,2.06 [1.60-2.66],2.4392270165445282e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,41880,443,1.59 [1.24-2.04],0.0002617412308004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,36388,394,0.24 [0.15-0.37],7.901859921411296e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,42620,454,0.73 [0.58-0.92],0.0081922077724114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,42620,454,1.51 [1.33-1.71],1.6467772044347055e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,42550,455,2.61 [2.03-3.36],9.921806655079856e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,41668,448,1.94 [1.64-2.29],3.492007604743133e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,36175,396,1.76 [1.47-2.10],7.686550216797568e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,36175,396,1.40 [1.09-1.81],0.0080963980469149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,43059,464,2.47 [1.71-3.56],1.2125468178741807e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,42620,456,0.77 [0.69-0.87],1.178366578111736e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,43147,461,1.69 [1.41-2.02],1.4491627151947833e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,37122,409,1.91 [1.43-2.56],1.2926440704594055e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,42847,457,0.57 [0.49-0.66],1.0313996409690766e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,43204,461,0.54 [0.40-0.74],9.890601206183168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,42793,461,0.55 [0.43-0.69],5.37035048393568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,42620,454,1.31 [1.08-1.58],0.0054702038175914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,37203,406,1.38 [1.13-1.68],0.0013259019329972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,37205,407,1.73 [1.24-2.41],0.0011169174250429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,42852,460,3.73 [2.65-5.23],2.7935405928815062e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,36175,396,0.80 [0.70-0.92],0.0014038444569087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,37205,407,1.99 [1.33-2.96],0.0007326819775782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,42691,456,2.13 [1.76-2.58],7.837736709837946e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,36382,391,2.00 [1.63-2.47],6.630556590273252e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,43204,461,2.41 [1.97-2.93],3.4688458816621165e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,42620,454,1.80 [1.52-2.12],3.139156599597349e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,42656,457,3.08 [2.32-4.08],6.101806740852297e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36223,386,1.45 [1.19-1.77],0.0002876110898598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42503,452,1.25 [1.11-1.41],0.0002181906920009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,42935,460,0.82 [0.72-0.93],0.0019571942461586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,42868,460,1.75 [1.38-2.21],3.058637527231875e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,42985,463,1.36 [1.10-1.69],0.0051136727966142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,37203,406,1.92 [1.37-2.69],0.0001632820439003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,42847,457,0.73 [0.61-0.88],0.0008573179865185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,42116,446,1.85 [1.53-2.24],2.621717571161496e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,36382,391,1.95 [1.51-2.52],4.015240401592793e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,41594,447,0.80 [0.72-0.89],3.4783060415532815e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,42656,457,1.80 [1.34-2.43],0.0001145615221818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,42864,461,3.88 [2.69-5.58],3.3058121478553374e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,43059,464,0.69 [0.60-0.79],1.2953575452946752e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,43204,461,0.56 [0.43-0.72],1.311417938289386e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,37122,409,1.19 [1.07-1.33],0.0018366155739524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,42864,461,3.20 [2.44-4.20],4.9791271990839007e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,37239,408,1.68 [1.36-2.09],2.297238014815316e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42367,453,1.31 [1.15-1.50],6.650818347173194e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,36116,394,1.44 [1.14-1.84],0.0026857580636211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,42777,455,2.12 [1.62-2.76],3.081061626249312e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,42723,460,1.16 [1.08-1.25],6.740607933779583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,42082,454,1.63 [1.36-1.96],1.5256325354436765e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,37205,407,2.41 [1.75-3.33],7.615132567336887e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,42688,457,0.76 [0.66-0.88],0.0003016757104349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,42655,458,0.73 [0.65-0.83],2.1781210516334174e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,37122,409,0.72 [0.63-0.82],7.813264782051282e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,42710,458,1.28 [1.10-1.49],0.0017547510842402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,42574,458,1.51 [1.25-1.82],1.5002694307403784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,39873,423,1.86 [1.57-2.20],3.508898598721717e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,42691,456,2.97 [2.15-4.10],3.607582554515672e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,43147,461,1.70 [1.31-2.21],5.618173436307703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,33538,355,2.75 [1.80-4.19],2.5135936413382195e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,42705,457,1.90 [1.47-2.46],1.1568942125211782e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,42620,454,1.86 [1.62-2.14],5.825711688302269e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,42864,461,1.27 [1.13-1.42],6.2614734151711e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,43074,461,1.29 [1.17-1.41],1.0772024252329429e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,41875,450,1.56 [1.27-1.92],2.3725538089433305e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,43074,461,1.34 [1.21-1.48],2.2765531812769243e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,43130,460,3.02 [2.15-4.24],1.7245214863814263e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,43147,461,2.06 [1.79-2.37],2.0868706099167134e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,43147,461,0.84 [0.76-0.95],0.0031944975850532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,42357,461,1.28 [1.16-1.42],2.5445716417827746e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,42864,461,1.43 [1.28-1.60],1.827874010584796e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,36620,400,1.36 [1.16-1.60],0.0001718898619152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,42864,461,1.28 [1.08-1.53],0.0055621630755233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42814,456,1.98 [1.57-2.49],7.203706378842795e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,42503,452,0.87 [0.79-0.96],0.0045625538489877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42503,452,1.64 [1.38-1.94],1.3824994066844964e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,42627,456,1.28 [1.09-1.50],0.0032788027557465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,43074,461,2.31 [1.72-3.12],3.516198676769619e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,43204,461,0.77 [0.67-0.90],0.0006523281361498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,42814,456,2.36 [1.83-3.06],6.293970365764703e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,42503,452,1.84 [1.39-2.43],2.3673430058688533e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,42620,454,1.58 [1.30-1.92],3.266247919850764e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,42503,452,0.68 [0.53-0.88],0.0025490255781033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,42350,452,1.49 [1.30-1.70],4.266231547178195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,42928,464,1.32 [1.17-1.49],1.1724752042304829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,42199,454,1.69 [1.35-2.11],4.02957604279888e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,36963,408,1.59 [1.31-1.93],2.447921962182009e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,42503,452,2.03 [1.50-2.76],5.052569487361163e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,43000,464,1.78 [1.40-2.26],2.6298151612547643e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37203,406,1.28 [1.14-1.43],2.585702296663121e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",36223,386,1.23 [1.11-1.36],6.810827678117726e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,43059,464,2.12 [1.75-2.56],7.492191541903228e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,42620,454,0.76 [0.69-0.84],1.6455357431833985e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,37037,409,0.71 [0.58-0.86],0.0003869182125391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41880,443,1.98 [1.61-2.43],6.75250861498929e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,36223,386,2.79 [2.05-3.79],5.827763903748049e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42774,456,2.56 [2.01-3.26],3.4437914144536174e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,42618,457,1.99 [1.52-2.60],4.977069710904496e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,42294,453,2.02 [1.60-2.54],2.7607522218805393e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,41668,448,1.59 [1.29-1.94],9.231266590561111e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,43204,461,0.16 [0.10-0.27],1.6019631058717557e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,42620,454,1.30 [1.16-1.46],6.354901750901478e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42691,456,1.24 [1.10-1.41],0.0007178338930331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,37203,406,1.89 [1.46-2.44],1.3817567672778578e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,41875,450,1.28 [1.08-1.53],0.0048370047083497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,43204,461,1.97 [1.21-3.20],0.0060193908995923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,36223,386,0.77 [0.64-0.92],0.0035193747773012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,43204,461,1.70 [1.25-2.30],0.0006620564912224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42864,461,0.73 [0.62-0.85],0.0001168967277455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41369,441,1.39 [1.25-1.53],1.7028612384573834e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41668,448,1.39 [1.16-1.67],0.0003191541856269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41880,443,2.08 [1.46-2.97],4.854491833351278e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,41191,443,2.44 [1.97-3.03],4.777435771285327e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,43204,461,2.48 [1.84-3.33],1.6148426576384044e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,42620,454,1.23 [1.12-1.36],1.5401071808161167e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,36223,386,1.26 [1.12-1.43],0.0001905048132824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42987,464,1.96 [1.53-2.50],6.609358776097811e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,42814,456,2.08 [1.50-2.88],1.0144053027340958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,43074,461,1.61 [1.18-2.20],0.0025831185576023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,42779,457,2.39 [1.50-3.80],0.000234470273084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",42656,457,1.39 [1.28-1.50],1.4051442640527313e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",42691,456,1.20 [1.08-1.32],0.0003679244750552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",37203,406,1.40 [1.18-1.65],8.152468803128573e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",43204,461,1.65 [1.42-1.92],3.5358575162242726e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,42929,460,1.20 [1.06-1.36],0.0031335544813844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,37203,406,2.33 [1.69-3.20],1.890016529977624e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,42503,452,1.60 [1.25-2.05],0.0001899447575976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,42627,456,1.46 [1.11-1.92],0.0062402496583367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,43062,460,1.37 [1.11-1.69],0.0035353642928445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,43147,461,0.72 [0.58-0.89],0.0030165168739111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,37205,407,2.08 [1.56-2.76],4.386935938048061e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",42691,456,1.36 [1.22-1.51],1.0670866913628398e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,42620,454,1.82 [1.53-2.16],1.0795327920882291e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42717,456,1.27 [1.07-1.52],0.0075758842203789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,37169,408,1.70 [1.40-2.07],8.355904084324598e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,42691,456,0.77 [0.64-0.93],0.0080671621503791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,41668,448,1.41 [1.26-1.57],1.9428603338824794e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",35986,394,1.29 [1.10-1.52],0.0022636494619293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,36379,392,1.97 [1.45-2.68],1.4117056131686336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,42864,461,1.19 [1.07-1.32],0.0018392368306548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,43000,464,1.38 [1.30-1.46],3.44153858715396e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,42992,464,1.42 [1.27-1.59],7.281057937494489e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,36116,394,1.33 [1.09-1.62],0.0041608169015173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,42814,456,0.59 [0.45-0.75],3.218719001022489e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,42814,456,3.27 [2.34-4.57],3.504657420176205e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,37239,408,2.16 [1.89-2.48],4.3294076593719733e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,41707,446,1.18 [1.04-1.34],0.0097108856924241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42367,453,1.51 [1.24-1.85],6.232229891546473e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42367,453,1.83 [1.37-2.43],3.681614635422775e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,42427,452,2.05 [1.54-2.74],1.1070934015963991e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,43147,461,1.62 [1.28-2.06],7.278127566685435e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,42635,454,1.71 [1.31-2.24],7.610100525643196e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,43074,461,2.03 [1.54-2.67],5.130455956234653e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,35828,395,1.44 [1.11-1.88],0.0067763661637587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,42795,460,1.39 [1.18-1.64],8.936651267163302e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,36223,386,5.23 [3.61-7.58],2.613086233940812e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,42599,458,3.16 [2.54-3.92],2.107499296082732e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,36382,391,1.39 [1.20-1.61],9.267567989530962e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,43074,461,2.07 [1.74-2.46],2.481962654773414e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42503,452,2.51 [1.88-3.34],3.068256134308153e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,43059,464,0.64 [0.46-0.88],0.0058520406259895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37203,406,2.45 [1.79-3.37],2.9615305599626984e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,42928,460,2.90 [2.11-4.00],5.565641520743278e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,35986,394,0.70 [0.55-0.89],0.0036008434173067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,37122,409,1.36 [1.28-1.45],3.69594679444898e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,37056,408,1.31 [1.14-1.52],0.0002411258310207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,35508,382,1.56 [1.33-1.82],6.082994704909128e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42503,452,1.39 [1.09-1.77],0.0080836917201144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,43204,461,2.18 [1.94-2.45],8.13709738654299e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,41707,446,1.37 [1.10-1.70],0.0047218124807032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,41668,448,1.26 [1.11-1.44],0.000435284749636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,43000,464,2.68 [2.06-3.49],2.713167248814661e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,36019,391,0.79 [0.67-0.93],0.0046340954825133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,41946,448,1.39 [1.10-1.76],0.0052210518853037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,42618,457,1.85 [1.62-2.11],5.949420125716321e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,42367,453,3.31 [2.42-4.53],7.55224219920002e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,42627,456,1.09 [1.04-1.14],0.000411294841997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,36382,391,0.48 [0.34-0.67],2.157090827426992e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,37122,409,2.11 [1.61-2.77],6.846978771017529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,40922,436,1.86 [1.37-2.54],8.58467239861348e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,36317,391,1.74 [1.35-2.24],1.874602314477518e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,42367,453,1.32 [1.08-1.61],0.0055791173362616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,41880,443,1.45 [1.25-1.68],8.112950290230305e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,36299,397,1.67 [1.39-1.99],1.789639102726712e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,43074,461,2.22 [1.61-3.08],1.5273387238364649e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",37205,407,1.46 [1.20-1.77],0.0001272497209102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,42367,453,0.64 [0.55-0.75],1.1965684477262275e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,37037,409,1.45 [1.23-1.71],1.025397448513178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,41707,446,1.47 [1.16-1.86],0.0014499067197523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,37041,407,1.38 [1.18-1.60],4.1831556831783285e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,41880,443,1.40 [1.23-1.59],4.99962525537271e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,37037,409,1.49 [1.30-1.71],1.0947267333852058e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,42474,454,2.12 [1.57-2.88],1.2579933807014468e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",42503,452,1.68 [1.49-1.88],7.593666321628609e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,37109,408,0.40 [0.27-0.59],3.7675983932814713e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,42473,456,1.42 [1.12-1.79],0.0036851793876068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,42866,459,1.53 [1.34-1.75],3.7238175471570606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,43059,464,1.12 [1.05-1.20],0.0004538466201301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,42997,461,1.79 [1.60-1.99],1.0051316580128796e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,42688,457,2.21 [1.78-2.74],6.336382379136367e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,42938,461,0.85 [0.76-0.96],0.0071956748207571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,36382,391,2.64 [1.88-3.71],1.8303574123155483e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,37203,406,1.85 [1.26-2.70],0.0015394960943761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,43147,461,2.73 [2.24-3.33],2.6618391653638923e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,37051,408,1.47 [1.25-1.73],3.3523273486664847e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,37147,408,1.31 [1.07-1.61],0.0098818407185669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",42500,449,1.49 [1.18-1.87],0.0006549861862138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",42620,454,2.13 [1.64-2.78],1.8567225592408933e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,41707,446,1.40 [1.20-1.64],2.608680632278097e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,42166,453,1.42 [1.20-1.69],5.810574635627854e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,41668,448,0.48 [0.38-0.60],5.26414576660897e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42620,454,1.66 [1.35-2.04],1.4458605036398957e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42349,451,2.47 [1.90-3.21],1.2024874689423808e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",42814,456,1.23 [1.08-1.41],0.0022867205261062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,42438,454,3.07 [2.22-4.25],1.3503425461486826e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,42493,454,3.36 [2.65-4.28],4.518220231428581e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,43204,461,1.80 [1.33-2.43],0.0001255662258288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,42691,456,2.16 [1.79-2.59],2.8214245453361073e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,43059,464,1.53 [1.27-1.84],6.619273109763709e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36136,397,2.58 [2.11-3.15],2.3792224630801846e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,42864,461,1.73 [1.20-2.50],0.003439368734787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,42367,453,1.38 [1.18-1.61],4.2303039761381136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,42503,452,1.61 [1.15-2.24],0.0052994661393909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,42688,457,2.25 [1.60-3.18],3.877804343055148e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,43133,461,1.29 [1.20-1.38],6.201518132780834e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,43134,461,1.64 [1.43-1.88],1.024308806678609e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,42847,457,0.40 [0.32-0.51],1.1377160076644944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,42136,451,1.92 [1.64-2.25],8.233723564600213e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,43204,461,2.50 [2.05-3.05],1.415545821302592e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,42691,456,3.00 [2.43-3.70],1.5372772837691299e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,37189,404,2.15 [1.72-2.69],1.5748278816578776e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,42503,452,1.82 [1.54-2.15],2.0254575563220214e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,42691,456,1.76 [1.37-2.28],1.3627928534843104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,37203,406,1.30 [1.17-1.45],1.2811519224395963e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,42864,461,2.73 [2.16-3.44],3.9036644617640206e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,42620,454,2.51 [1.99-3.16],1.0955782425569746e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,41875,450,1.51 [1.18-1.93],0.0010947013819175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,41805,449,1.34 [1.14-1.58],0.000362977370507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,41875,450,1.37 [1.23-1.52],1.4072614365025962e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,42511,455,1.76 [1.49-2.09],8.709729896924465e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,42847,457,2.63 [2.07-3.34],1.9740971556292483e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,43147,461,1.88 [1.48-2.38],1.7841888963508937e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,41625,448,1.57 [1.42-1.73],1.525346793466958e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,41672,447,1.27 [1.11-1.44],0.0003817647474939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,42618,457,2.41 [1.72-3.38],3.567360876386568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,42688,457,0.55 [0.45-0.68],2.7594427389749392e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,43062,460,2.14 [1.79-2.55],3.494671156462024e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,41875,450,0.42 [0.34-0.52],1.275043033699317e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,42575,459,1.54 [1.36-1.75],1.5994445352928168e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,37037,409,1.67 [1.49-1.88],1.1398057584056925e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,42368,452,2.35 [1.96-2.83],8.917439751810782e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,42620,454,1.64 [1.39-1.94],4.7868805786077595e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,36116,394,1.23 [1.06-1.43],0.0064589901531786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,35977,394,1.24 [1.09-1.41],0.0007754609788845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,42620,454,2.24 [1.85-2.71],1.2014218168075786e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,42503,452,1.53 [1.42-1.66],2.781348666034201e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,42691,456,3.46 [2.18-5.50],1.345562523970599e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,42688,457,0.80 [0.69-0.93],0.0041680059463197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,37037,409,1.58 [1.32-1.89],4.334583659346072e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,36382,391,1.71 [1.44-2.03],8.078224848180206e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,37122,409,0.68 [0.61-0.76],1.0223776890384347e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,37041,407,1.18 [1.07-1.30],0.0005947196388963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,36116,394,3.39 [1.97-5.82],1.0081945329475356e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,42620,454,1.41 [1.14-1.75],0.0016409037610211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,42620,454,0.60 [0.47-0.76],3.531590824616193e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,36382,391,0.59 [0.44-0.79],0.0003908036803159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,42688,457,2.83 [2.06-3.89],1.6265522794862575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,42688,457,0.68 [0.52-0.89],0.0048861743533295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,43059,464,0.33 [0.20-0.53],3.695088177900462e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,43059,464,1.31 [1.10-1.56],0.0020039659504924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,37205,407,2.04 [1.66-2.52],2.4295589420678668e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42847,457,2.22 [1.77-2.78],3.0517873113592068e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,41875,450,1.36 [1.18-1.56],1.496748297802024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,35986,394,1.42 [1.15-1.77],0.0012905372066275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,42779,457,0.55 [0.41-0.72],2.853699878740421e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,42691,456,0.48 [0.39-0.59],7.17006272441678e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,42687,454,1.71 [1.42-2.07],2.4636381291161893e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,42414,453,1.90 [1.54-2.34],1.6444154243157115e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,43059,464,1.41 [1.18-1.67],0.0001012891234456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,37205,407,0.81 [0.73-0.90],0.000100532218248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,43059,464,1.39 [1.24-1.56],2.995791335272127e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,41259,438,1.59 [1.26-2.01],9.268895747974118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,36496,399,0.56 [0.38-0.83],0.0037741548890671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",42503,452,1.25 [1.14-1.37],3.3706413385748057e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",42550,453,1.29 [1.16-1.45],8.446785380972396e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",35984,403,1.19 [1.07-1.33],0.0011907142092538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,43147,461,1.38 [1.16-1.64],0.0003244437724056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42656,457,1.86 [1.57-2.21],1.1019467307766866e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,42864,461,1.59 [1.25-2.01],0.0001245858909123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,36145,397,1.54 [1.21-1.96],0.0003718269314348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,43075,460,1.82 [1.58-2.10],7.114700564780712e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,42293,453,2.10 [1.69-2.60],1.4387833575812828e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,42847,457,1.47 [1.28-1.68],5.729813169070545e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,43074,461,1.19 [1.07-1.33],0.0019209244779274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,37239,408,0.44 [0.31-0.64],1.6351248833825256e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,41375,440,1.49 [1.23-1.81],4.272079427335049e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,42794,456,0.77 [0.66-0.91],0.002014088625635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,35153,376,1.33 [1.17-1.53],2.900586486384814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,37147,408,1.48 [1.16-1.89],0.0014860300002313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,42691,456,1.73 [1.37-2.18],3.1893756818279862e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,37147,408,1.30 [1.10-1.54],0.0025007833386574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,42796,459,1.80 [1.38-2.35],1.7576787591233963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,37249,405,2.15 [1.66-2.80],9.199779569677813e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,42656,457,1.96 [1.71-2.24],2.27183523363622e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,42563,459,1.35 [1.12-1.62],0.0013247128260983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,42654,459,2.67 [2.11-3.39],3.3925997296655543e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,42864,461,2.36 [1.90-2.94],1.5710583851887735e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,42620,454,2.26 [1.67-3.05],1.072069171419448e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42688,457,1.66 [1.30-2.12],5.0214123660074114e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42627,456,2.30 [1.78-2.97],1.4833135253149115e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37203,406,1.21 [1.06-1.38],0.0057847310128232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,43204,461,1.64 [1.21-2.23],0.0015404817064394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42992,460,1.50 [1.16-1.92],0.0017767830954512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41875,450,1.44 [1.19-1.74],0.0001629401984158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,37122,409,1.80 [1.32-2.46],0.0002018536493483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,37147,408,1.51 [1.20-1.90],0.0003844188752921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,41286,445,1.31 [1.14-1.51],0.0001177301025211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,37249,405,3.29 [2.36-4.58],2.1730308623898866e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,42503,452,1.67 [1.24-2.26],0.000750628077508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,42691,456,1.38 [1.10-1.73],0.0054325419678545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,42503,452,1.92 [1.60-2.30],1.55098462361646e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,41875,450,0.45 [0.37-0.56],1.1577470125366753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,43204,461,2.46 [1.96-3.09],7.231085666138904e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,41668,448,1.42 [1.24-1.62],2.3180837532931518e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,42442,455,2.60 [2.01-3.37],3.82913076554197e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,42436,457,1.44 [1.18-1.77],0.0003530737037768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,42197,445,1.75 [1.33-2.30],6.22554370836908e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,42367,453,2.39 [1.97-2.91],2.892285074441517e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,41668,448,1.30 [1.12-1.52],0.0007862357190603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37249,405,2.81 [1.71-4.62],4.4535067641280895e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,35893,396,0.52 [0.38-0.72],7.612155456429878e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42219,452,1.26 [1.10-1.46],0.0012409294105983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,37203,406,1.69 [1.31-2.20],6.831900278483198e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,42814,456,1.72 [1.28-2.31],0.0002858321322821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,42691,456,1.96 [1.42-2.71],4.93691755124584e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,42726,459,2.87 [2.19-3.76],2.3692026091339515e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,42691,453,1.58 [1.38-1.81],5.542120477248543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,36382,391,0.53 [0.35-0.81],0.0030186550105895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,42691,456,0.76 [0.71-0.81],2.3877591886019832e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,42656,457,0.55 [0.40-0.75],0.0001354697272575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,43147,461,1.89 [1.38-2.59],7.890979858252946e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,36382,391,1.67 [1.24-2.24],0.0006246827322207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,42688,457,1.43 [1.19-1.71],0.0001121624851643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42620,454,1.15 [1.07-1.24],9.189053375901804e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,41875,450,1.48 [1.26-1.73],1.0174467705628068e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,42503,452,1.29 [1.16-1.42],1.1977805484161066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,41125,434,1.24 [1.12-1.38],3.267079455304626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,42586,457,1.41 [1.23-1.61],4.652923824529447e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,42736,459,2.04 [1.78-2.34],2.3853959477017342e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,41814,442,2.22 [1.85-2.67],2.560645713353568e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,43004,460,1.47 [1.33-1.64],5.003541459254109e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,42619,457,1.58 [1.38-1.82],7.944852371259829e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,42632,455,1.11 [1.03-1.20],0.0083559660115095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,42688,457,1.38 [1.17-1.62],0.0001320526663266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,37239,408,4.67 [3.47-6.29],2.735212728621167e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,42435,452,1.57 [1.40-1.77],9.010610647493965e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,43074,461,2.19 [1.85-2.60],1.746396798244108e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,41880,443,0.58 [0.50-0.68],2.565555846579503e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,36507,400,1.38 [1.19-1.60],2.113128159871312e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,41707,446,1.28 [1.10-1.50],0.0015141631689501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,41875,450,1.36 [1.23-1.50],8.19662102971885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,42795,460,1.91 [1.65-2.21],5.09595585790429e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36382,391,2.23 [1.42-3.50],0.0004912351840666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,41668,448,1.23 [1.08-1.41],0.0023121006619707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,42814,456,2.11 [1.57-2.85],8.627999320802045e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,43074,461,0.62 [0.49-0.76],1.2131640754277058e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,42551,453,1.19 [1.09-1.30],0.00014088990929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37041,407,1.88 [1.46-2.41],9.107475106083224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,43059,464,1.49 [1.11-1.98],0.0070776985467473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,42627,456,2.37 [1.85-3.02],5.2449826210456906e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,42814,456,1.79 [1.43-2.24],2.8006777189855214e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,41577,444,1.59 [1.34-1.89],7.723875966130458e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,42814,456,0.74 [0.60-0.90],0.003057574481744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,43147,461,2.22 [1.70-2.90],6.066969942871307e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41875,450,1.53 [1.36-1.73],2.9273359176235e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,35523,385,2.78 [2.02-3.81],2.4130247225705916e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,42706,456,1.38 [1.11-1.72],0.0039195940469356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,36223,386,0.71 [0.57-0.88],0.0021316789530174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,42726,459,2.14 [1.60-2.85],2.284896596384381e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",41707,446,1.45 [1.27-1.65],4.102977027225333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,43204,461,1.38 [1.09-1.74],0.0070705765806395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,36579,400,2.42 [1.96-3.00],5.141291103028676e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,42691,456,1.89 [1.53-2.35],5.946690018952541e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,37203,406,1.44 [1.18-1.77],0.0003514833188427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,41880,443,1.17 [1.09-1.25],6.274390778232796e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,42688,457,1.60 [1.33-1.93],6.824277515492614e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,37205,407,1.89 [1.42-2.51],1.287523931891464e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,42691,456,0.63 [0.48-0.81],0.0004634356649694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,42920,457,2.18 [1.62-2.93],2.877088103468441e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,37122,409,2.20 [1.78-2.71],2.8897648847334e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,42814,456,1.41 [1.23-1.63],2.0692123257397776e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,43074,461,0.50 [0.34-0.73],0.0003916821396584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,42691,456,1.31 [1.23-1.41],1.3772029226339932e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,37147,408,2.49 [2.10-2.95],7.048036423848574e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,41639,442,0.72 [0.61-0.87],0.0003917368798356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,42688,457,1.45 [1.20-1.75],0.0001397122004264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,35037,379,1.15 [1.06-1.25],0.0011778816335222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,42273,451,1.37 [1.21-1.54],4.266344135676354e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,42503,452,0.72 [0.64-0.82],3.782518458200386e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,37115,405,2.39 [1.52-3.78],0.0001805871320921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,42726,459,2.62 [2.04-3.36],3.858794331657282e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,42412,450,1.49 [1.33-1.67],1.0201436233219376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,42920,457,4.77 [3.23-7.04],4.249035924429053e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,43074,461,1.09 [1.03-1.16],0.0020624611799909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,42479,450,1.39 [1.12-1.73],0.0025188108617442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,37122,409,2.40 [1.97-2.92],1.6198507878685354e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,37147,408,1.78 [1.26-2.53],0.001204969148691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,37037,409,1.43 [1.14-1.81],0.0024109085342454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,43204,461,1.56 [1.27-1.92],2.5827829534805025e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,42503,452,1.56 [1.20-2.02],0.0008831977854239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,42691,456,1.56 [1.17-2.08],0.0021714270910442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,35986,394,1.23 [1.05-1.43],0.0097120914364012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36116,394,1.65 [1.38-1.97],4.5210667031485264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,37239,408,1.52 [1.33-1.74],5.216113102195913e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,43147,461,2.10 [1.67-2.65],3.4087437527073687e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,42992,460,1.38 [1.15-1.65],0.0005370644409696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,37041,407,1.34 [1.12-1.59],0.0013631803644806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,42117,453,1.61 [1.42-1.84],6.83687477645068e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,42136,452,3.71 [3.08-4.48],6.46548764695714e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42688,457,1.74 [1.33-2.29],6.934241424046134e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,42688,457,2.08 [1.70-2.55],8.076221511762945e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,42691,456,1.56 [1.33-1.82],3.653962826105664e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,37203,406,2.33 [1.63-3.32],3.0999937283463624e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,42814,456,4.54 [3.44-5.98],5.4119119466672e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,43134,461,0.55 [0.46-0.66],4.4676141609838735e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",42583,457,1.39 [1.23-1.57],1.859293760846132e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,42688,457,0.53 [0.41-0.68],5.469688408221102e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,43062,460,1.70 [1.44-2.00],1.4678356358215708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,42688,457,1.98 [1.60-2.45],2.927852991655616e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,42375,455,5.43 [4.27-6.92],4.3138552265762425e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,36299,394,1.85 [1.19-2.87],0.0060680672169315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,42993,460,2.45 [1.77-3.38],5.397115394142991e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,36175,396,1.29 [1.07-1.55],0.0064752545579263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,37239,408,0.76 [0.65-0.88],0.0001718930164221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,36116,394,1.46 [1.20-1.79],0.000188996615472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42503,452,1.50 [1.24-1.81],2.14240337524154e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,36223,386,0.77 [0.67-0.88],0.0001703935231309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,41880,443,1.71 [1.34-2.18],1.637385452674924e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,42864,461,0.70 [0.56-0.88],0.002557873854265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,36116,394,1.57 [1.19-2.06],0.0013798838817429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37147,408,1.56 [1.26-1.94],5.43480295032625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,37205,407,2.20 [1.70-2.83],1.27626929427423e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,42938,460,1.72 [1.33-2.20],2.52795456996686e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41875,450,1.21 [1.08-1.36],0.0010181385390024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,43059,464,0.83 [0.72-0.95],0.008554309752127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,37205,407,1.46 [1.22-1.75],3.8550939240082704e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,37205,407,1.32 [1.09-1.61],0.004789160113851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,37122,409,1.56 [1.31-1.85],4.2573175455468905e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,36116,394,2.03 [1.68-2.46],2.315471240380652e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,37122,409,1.42 [1.11-1.82],0.0052515012913395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,42505,459,2.66 [2.23-3.18],4.0578778191075376e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,43059,464,2.30 [1.70-3.12],7.475692175905443e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,36507,400,1.59 [1.21-2.09],0.0009803871121575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,36854,402,2.52 [1.95-3.25],1.1457237731203018e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,42367,453,1.20 [1.10-1.31],2.679233063071728e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,42352,453,1.42 [1.10-1.84],0.0069695602992171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,37203,406,1.17 [1.05-1.31],0.0061790616993399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,41707,446,1.75 [1.41-2.16],2.754893968717997e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,41880,443,1.74 [1.48-2.03],8.50351153021842e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,37203,406,1.75 [1.29-2.39],0.0003734707309839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37041,407,1.89 [1.31-2.72],0.0006043011712137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,43204,461,0.59 [0.42-0.82],0.0020144739450574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37203,406,1.75 [1.30-2.36],0.0002279653609145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,41518,441,1.25 [1.08-1.44],0.0024375759686165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,42620,454,1.60 [1.32-1.95],2.3526805285051934e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,43074,461,2.27 [1.88-2.74],1.5869097621197254e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,42728,459,1.69 [1.24-2.31],0.0008464834987207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,36501,400,1.37 [1.15-1.64],0.0004135283852272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,42620,454,0.63 [0.52-0.76],1.4634886982594385e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,41668,448,1.21 [1.06-1.39],0.0058194612591014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,42920,457,1.44 [1.24-1.68],3.3457552625398767e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,41668,448,1.20 [1.06-1.36],0.003795624392185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,37147,408,1.92 [1.60-2.29],1.243234875622276e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,41689,444,1.26 [1.06-1.49],0.0072994115019119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,42503,452,1.34 [1.21-1.49],4.6440908478876194e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,42503,452,1.36 [1.18-1.56],1.5978855694259057e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,37041,407,1.30 [1.14-1.49],0.0001192743792802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,42431,455,1.43 [1.23-1.66],4.580311524789843e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,43204,461,1.26 [1.10-1.44],0.0009318467821905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,43204,461,1.34 [1.19-1.52],2.0442797524079725e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,42726,459,1.36 [1.15-1.59],0.0002192728606209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,36116,394,1.35 [1.15-1.59],0.0003120553534553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,42688,457,1.72 [1.31-2.26],7.990492692783864e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,42691,456,1.52 [1.39-1.67],2.8061451560844845e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42503,452,0.69 [0.55-0.86],0.0010465364602467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,43074,461,0.62 [0.48-0.81],0.0005433693563913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,37239,408,2.51 [1.86-3.40],2.606268503926692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,36035,392,2.29 [1.69-3.10],9.538430128904353e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,36980,407,2.15 [1.77-2.61],1.1414129470692634e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,43005,460,2.75 [2.09-3.62],6.571115162279281e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,36223,386,2.63 [1.99-3.47],8.014749762481955e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,42726,459,2.10 [1.51-2.91],8.706743862223689e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,41668,448,1.35 [1.18-1.55],1.8191123707897176e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,42367,453,1.66 [1.32-2.08],1.4930410034569996e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,43059,464,1.55 [1.17-2.05],0.0020460072362242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,43059,464,0.69 [0.54-0.88],0.0032501692029669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,42355,451,1.35 [1.17-1.56],4.66055496337333e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,42085,444,1.23 [1.10-1.38],0.0003704169227648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,41639,442,1.24 [1.09-1.41],0.0013310379572176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,37147,408,1.33 [1.11-1.60],0.0023405445417562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,37136,407,1.58 [1.20-2.07],0.0010540580098942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,41564,442,1.86 [1.47-2.36],2.187495359799831e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,43204,461,1.33 [1.09-1.61],0.0041424092055238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,43074,461,2.33 [1.76-3.10],3.873434472544707e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,42724,459,0.60 [0.53-0.69],3.1626289497809077e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,36382,391,2.11 [1.46-3.04],6.23800975353715e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,42795,460,1.20 [1.10-1.31],2.7942977912243168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,42938,461,1.59 [1.36-1.86],1.0063594150277698e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,41668,448,1.18 [1.07-1.31],0.0016218399978367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,36083,386,1.37 [1.13-1.66],0.0011360532742615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,36175,396,0.61 [0.49-0.76],1.07520102275967e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,42691,456,1.41 [1.17-1.70],0.0003563830200364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,42691,456,0.74 [0.62-0.88],0.0006093712832828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,37041,407,1.29 [1.13-1.46],0.0001343294206989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,36223,386,1.58 [1.26-1.98],7.76422352901261e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,43204,461,1.51 [1.27-1.79],2.7123707440617265e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,37249,405,0.26 [0.17-0.40],1.0797759956307199e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,37147,408,1.26 [1.12-1.42],0.0001635044625333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,37054,407,2.16 [1.71-2.74],1.6703810990726704e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,36554,400,6.67 [2.63-16.91],6.345093537404742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,43204,461,1.94 [1.58-2.40],3.8744631468970916e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,37119,404,3.91 [2.36-6.48],1.218107319659175e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,36583,398,0.41 [0.27-0.62],1.6322344616997215e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,36714,401,0.62 [0.44-0.87],0.0051126670377642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,37249,405,2.69 [1.55-4.68],0.0004626973588827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,42305,448,1.19 [1.07-1.34],0.0020351059013819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,43147,461,1.23 [1.09-1.38],0.0007273646536365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,37174,404,0.34 [0.18-0.64],0.0009926451293048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,37174,404,1.82 [1.29-2.55],0.0005643435607055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,36552,400,0.36 [0.17-0.74],0.0058861103725318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,37174,404,3.14 [1.88-5.24],1.1667482019290949e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,42503,452,2.21 [1.64-2.99],2.6615527449853575e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,42223,452,1.57 [1.32-1.86],2.355415076548388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,41668,448,1.28 [1.12-1.45],0.0001965699224533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,41668,448,1.44 [1.26-1.65],1.1190623747641444e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,36596,402,1.25 [1.06-1.48],0.0090402654922204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,37239,408,1.71 [1.39-2.10],2.4975991931714465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,37205,407,2.71 [2.11-3.48],4.405148085170502e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,42740,454,1.52 [1.27-1.82],3.5930136654634368e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,42864,461,2.20 [1.83-2.63],1.8516541148236518e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,42620,454,1.96 [1.57-2.44],2.794098455983896e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,42691,456,2.30 [1.72-3.08],2.4776586207436256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,36223,386,1.36 [1.10-1.68],0.0046589130197328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,42997,461,1.81 [1.37-2.39],2.783947382051825e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42780,459,1.24 [1.06-1.45],0.0070446412936603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,42583,456,1.53 [1.28-1.83],2.5093575309048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,41875,450,1.38 [1.19-1.60],1.5345900592390518e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,41668,448,1.45 [1.17-1.80],0.000665013620825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,42620,454,1.50 [1.32-1.72],1.7698372907709279e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,41668,448,1.72 [1.46-2.03],1.1067420074413252e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,41707,446,1.33 [1.18-1.51],5.393558556763612e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,35893,396,0.73 [0.57-0.93],0.0095528767470831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,41707,446,1.31 [1.13-1.53],0.000416071113075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,36116,394,0.61 [0.45-0.83],0.0014642482716849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,43059,464,0.70 [0.57-0.86],0.0006544325658061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,43059,464,1.47 [1.15-1.89],0.0022230558364685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,42864,461,1.88 [1.53-2.30],9.751138875004808e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,42871,459,1.72 [1.48-1.99],1.9350909440466346e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36223,386,1.50 [1.13-1.98],0.005060073886251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",42688,457,1.93 [1.60-2.32],6.633080692370189e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,37147,408,1.40 [1.16-1.68],0.0003858269695035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,41668,448,1.56 [1.24-1.96],0.000170110778365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,42627,456,0.68 [0.55-0.85],0.0005729760778587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,42688,457,1.70 [1.44-2.01],4.6177630309669454e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,42620,454,1.24 [1.09-1.40],0.0008508742391321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,42549,456,2.70 [2.13-3.42],2.7815067858193113e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,42864,461,1.40 [1.14-1.72],0.0015121171087573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,37041,407,0.91 [0.86-0.97],0.0027048660460549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,42726,459,2.53 [2.04-3.15],5.316557100234399e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,42485,454,2.73 [2.20-3.40],1.5471435143305297e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,43134,461,1.55 [1.30-1.84],7.957955817051035e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,37203,406,1.68 [1.28-2.20],0.0001940214282317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42627,456,0.69 [0.64-0.75],7.566516637792895e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42503,452,1.34 [1.11-1.61],0.0019234400624274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",43204,461,2.30 [1.80-2.94],3.083099098439918e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,37205,407,1.73 [1.24-2.42],0.0012941992275326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,43074,461,1.36 [1.14-1.63],0.0007249537406255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,42620,454,1.48 [1.33-1.66],2.439792004479109e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,42688,457,2.16 [1.71-2.73],9.37587972998459e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,37041,407,1.39 [1.09-1.77],0.0078769996058242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,37842,411,1.92 [1.46-2.53],2.937038463200224e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,42503,452,1.61 [1.30-2.00],1.6492469705848334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,36497,402,1.87 [1.49-2.35],5.4272750690741424e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,43134,461,2.03 [1.59-2.59],1.0091172328901897e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,37203,406,1.48 [1.14-1.92],0.0029358620415454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,37203,406,2.34 [1.72-3.20],8.437593960897438e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",36175,396,1.39 [1.14-1.69],0.0013488258772692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,36175,396,0.73 [0.61-0.88],0.0010540323809399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,42478,454,1.45 [1.33-1.59],1.1427718879370673e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,42795,460,2.15 [1.92-2.42],1.0817979394458222e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,42640,452,1.70 [1.48-1.96],1.2082708699727897e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,42683,454,1.60 [1.41-1.83],1.874403618548552e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,37037,409,0.88 [0.79-0.97],0.0092162139369214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,42620,454,1.86 [1.60-2.17],7.276196836874887e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,43075,460,1.79 [1.46-2.19],2.248903149950731e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,42425,454,1.57 [1.15-2.15],0.0042890568562904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,42814,456,2.04 [1.65-2.53],6.43580068062889e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,43204,461,1.71 [1.30-2.25],0.0001116056301983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,37239,408,1.70 [1.19-2.44],0.0037923084617142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,42688,457,2.50 [2.11-2.96],3.3935447892262024e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,42706,456,1.42 [1.19-1.70],0.000131124562971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,43074,461,1.64 [1.24-2.17],0.0005620713381744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,43204,461,1.47 [1.17-1.86],0.0010242444053699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41633,446,1.34 [1.13-1.60],0.0008619820316784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42847,457,1.44 [1.20-1.74],0.0001274774290783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,42213,449,2.78 [2.18-3.53],6.537405769688508e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,37203,406,1.44 [1.10-1.89],0.0074527655938252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,42864,461,1.10 [1.03-1.17],0.0023453653166628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,42688,457,2.50 [2.10-2.97],9.518957992496336e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,36116,394,1.72 [1.23-2.39],0.0013786310839625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,37054,407,1.80 [1.43-2.26],5.399599683376131e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,42847,457,1.76 [1.49-2.08],3.560790624633739e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,41825,443,1.44 [1.21-1.72],5.640894253205384e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37041,407,1.28 [1.08-1.53],0.0054761049294619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42367,453,2.69 [2.21-3.28],7.023985541202161e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42367,453,1.61 [1.44-1.79],6.974892249562915e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42783,459,1.35 [1.14-1.61],0.0006707531920565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,43147,461,1.66 [1.36-2.02],3.937196316216933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42656,457,3.42 [2.67-4.37],1.5443601826417322e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42814,456,2.19 [1.79-2.68],4.3382180578598114e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42726,459,1.33 [1.07-1.65],0.0092688711683958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42726,459,2.05 [1.60-2.63],1.2239685057257728e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42688,457,2.63 [2.08-3.33],1.1545439134928725e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42688,457,1.80 [1.55-2.08],5.391438154653717e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,43074,461,2.08 [1.56-2.77],5.14147514091735e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,43075,460,1.79 [1.46-2.19],1.661779308532275e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42367,453,1.75 [1.55-1.98],6.480972456335695e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,43074,461,1.33 [1.12-1.59],0.0012915618638369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42367,453,1.54 [1.30-1.83],7.160917232002817e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,43147,461,0.62 [0.45-0.84],0.002359035158239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,42620,454,0.75 [0.65-0.86],2.66471751733151e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,43147,461,0.47 [0.35-0.63],3.7220838055249473e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,42864,461,2.49 [1.86-3.35],1.3262030705899722e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,43130,460,2.66 [2.11-3.34],7.602757233008382e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,42367,453,1.25 [1.09-1.45],0.0018361407375634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,37205,407,1.55 [1.21-1.98],0.0005069708605363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,42367,453,0.61 [0.50-0.74],1.0598176179581589e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,42378,455,1.80 [1.56-2.07],8.49928966093245e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,42656,457,1.78 [1.54-2.05],6.673491660190546e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,43059,464,1.20 [1.05-1.37],0.0071200198174297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,41880,443,0.76 [0.64-0.91],0.0023930891676976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,37041,407,1.30 [1.18-1.43],1.2939215333846388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,36846,401,0.37 [0.26-0.52],2.1269082004160632e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,42814,456,2.47 [1.86-3.27],3.492219575831205e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,43074,461,1.21 [1.07-1.36],0.00183159239522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,42691,456,1.63 [1.21-2.20],0.00140494206735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,42367,453,1.90 [1.55-2.33],4.410292554439989e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,43066,459,0.72 [0.62-0.83],7.620413727733109e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,41880,443,1.49 [1.32-1.69],8.578622685489918e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,42779,457,2.05 [1.55-2.72],6.203739585011689e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,43074,461,1.69 [1.29-2.21],0.0001316909660974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,43007,461,1.41 [1.23-1.62],6.127368158161723e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,36116,394,2.47 [1.76-3.45],1.478757198471036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,43074,461,1.40 [1.12-1.76],0.0036183957646925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,37203,406,1.54 [1.19-1.99],0.0009469829678121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,37239,408,1.24 [1.07-1.42],0.0034333555040878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,42503,452,1.93 [1.58-2.35],8.358092285624898e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,37037,409,1.94 [1.70-2.21],7.48788767302935e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,42636,455,1.98 [1.64-2.39],6.07316056243248e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,41707,446,1.26 [1.06-1.50],0.0081654544971098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,41668,448,1.58 [1.22-2.04],0.0005976735442314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,43000,464,2.11 [1.76-2.52],8.727593619993927e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,43204,461,1.26 [1.13-1.42],4.616181770528252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",42688,457,1.51 [1.20-1.89],0.0003801053754557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,42985,463,1.33 [1.17-1.51],9.347529186869952e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,40551,426,2.42 [2.06-2.84],1.964728807427069e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42223,451,0.31 [0.25-0.38],2.5221692455703434e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,43059,464,1.43 [1.13-1.81],0.0027731011358608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,41875,450,1.69 [1.30-2.20],7.674444616112754e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,43059,464,1.24 [1.08-1.43],0.0026266901518803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,37122,409,2.43 [1.83-3.23],9.62745334688145e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,41880,443,1.46 [1.24-1.71],3.8960239672627774e-06
